Form 4 Filing for MAHONEY DAVID L

2026-06-18SEC Filing 4 (0001193125-26-275963)

David L. Mahoney, a director at CORCEPT THERAPEUTICS INC (CORT), reported a sale of 20,000 shares of Common Stock on June 17, 2026. The weighted average sale price was $84.5253, with actual prices ranging from $84.44 to $85.11. Following this transaction, Mahoney directly owns 26,147 shares. Additionally, he is indirectly associated with 1,237,145 shares held by the David L. Mahoney and Winnifred C. Ellis 1998 Family Trust. The filing also notes a power of attorney on file with the Commission and that specific sale price details are available from the issuer upon request.